Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 11181-11190

  Means, R E ^a   Desrosiers, R C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DODECYL SULFATE SODIUM; GLYCOPROTEIN; GLYCOSIDASE; MANNOSIDASE; MERCAPTOETHANOL; N ACETYL BETA GLUCOSAMINIDASE; N ACETYLNEURAMINIC ACID; SIALIC ACID DERIVATIVE; SIALIDASE;

ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; DIGESTION; ENZYME DENATURATION; ENZYME MECHANISM; HUMAN; HUMAN CELL; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RESISTANCE;

ANIMALS; GLYCOSIDE HYDROLASES; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; HUMANS; MACACA MULATTA; NEURAMINIDASE; PROTEIN DENATURATION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0034469405     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.11181-11190.2000     Document Type: Article

References (47)

1. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation
2. An EGFP-containing vector system that facilitates stable and transient expression assays
3. N-linked oligosaccharides of simian immunodeficiency virus envelope glycoproteins are dispensable for the interaction with the CD4 receptor
4. Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160
5. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160
6. Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein
7. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells
8. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules
9. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis
10. The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding
11. N-Butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure
12. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity
13. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120
14. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase
15. HIV acquires functional adhesion receptors from host cells
16. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization
17. Glycosylation of the envelope glycoprotein gp130 of simian immunodeficiency virus from sooty mangabey (Cercocebus atys)
18. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface
19. Myxoma virus encodes an α2,3-sialyltransferase that enhances virulence
20. Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120
21. Assembly of asparagine-linked oligosaccharides
22. Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein
23. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1
24. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding
25. Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4
26. Oligosaccharide profiles of HIV-2 external envelope glycoprotein: Dependence on host cells and virus isolates
27. Host-cell-specific glycosylation of HIV-2 envelope glycoprotein
28. Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells
29. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus
30. N-glycosylation and the avoidance of humoral immunity
31. Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues
32. Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors
33. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1
34. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21)
35. Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity
36. The HIV replication inhibitor 3′-fluoro-3′-deoxythymidine blocks sialylation of N-linked oligosaccharides
37. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques
38. Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation
39. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity
40. Glucosidase inhibitors for treatment of HIV-1 infection
41. Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity
42. Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein
43. A role for carbohydrates in immune evasion in AIDS
44. Desialylation of peripheral blood mononuclear cells promotes growth of HIV-1
45. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine
46. Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures
47. Facilitation of HIV-1 isolation from patients by neuraminidase